IFEZ 인천경제자유구역 로고

On March 27, 2023 (Monday), IFEZ signed an investment agreement with Osang Healthcare. With the signing of this investment contract, research and manufacturing facilities in the field of in vitro diagnosis will be built on 14,716㎡ of the Sr-13 parcel (178-5 Songdo-dong) of the Incheon Techno Park expansion construction complex in Songdo International City 7. Osang Healthcare is a company specializing in in vitro diagnosis such as molecular diagnosis, immune diagnosis, and biochemical diagnosis. It supplies products to more than 100 countries around the world, and most of its sales are generated overseas, and it is widely known in Korea through COVID-19 diagnostic kits. The company's COVID-19 diagnostic kit has been approved for emergency use by the U.S. Food and Drug Administration (FDA) for the first time in Korea and is recognized for its high-quality product supply capabilities.